News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Pharm Country
GlaxoSmithKline Plan to Enter RTE Market in India
April 27, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
StocksandShares -- GlaxoSmithKline plc (LON:GSK), the consumer healthcare company, announced its plan to enter into the ready-to-eat (RTE) market in India by launching new products for children and women.
Twitter
LinkedIn
Facebook
Email
Print
Asia
GlaxoSmithKline
MORE ON THIS TOPIC
Lung cancer
Summit’s Bispecific Beats Yet Another Cancer Med, Pressuring Keytruda’s ‘Supremacy’
April 23, 2025
·
2 min read
·
Tristan Manalac
Government
Lawmakers Seek to Boost US Biotech Sector, Keep China’s Growth in Check
April 11, 2025
·
2 min read
·
Tristan Manalac
China
Amid Trade Tensions, Commission Warns China is ‘Dangerously Close’ to Overtaking US Biotech
April 9, 2025
·
2 min read
·
Tristan Manalac
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
April 7, 2025
·
2 min read
·
Tristan Manalac
